16,058 findings · published 2017+
- Metabolic adaptationStrong
Both groups experienced an improvement in cardiometabolic risk markers after 12 months.
Improvements in cardiometabolic health may accompany weight loss in postmenopausal women.
Supports 2024 - Energy balanceStrong
Mean total daily energy expenditure (TEE) for female soccer players was 2693 ± 432 kcal·d-1 over 12 days.
Practitioners should consider these energy expenditure values when planning nutrition for female soccer players.
Supports 2022 - Energy balanceStrong
88% of players were categorized with low energy availability (EA) status according to the threshold of <30 kcal·kg-1 FFM.
Practitioners should address energy availability to optimize player health and performance.
Supports 2022 - Energy balanceStrong
Mean daily carbohydrate intake was 3.3 ± 0.7 g·kg-1 body mass.
Practitioners should ensure adequate carbohydrate intake for optimal performance.
Supports 2022 - MolecularStrong
Protein-polyphenol drink ingestion likely accelerates recovery of muscle function by attenuating inflammatory NF-κB transcriptional signaling.
Incorporating protein-polyphenol drinks may enhance recovery from muscle damage.
Supports 2021 - CellularStrong
Eccentric contractions impaired muscle function for 48 hours in the placebo group but only for 24 hours in the protein-polyphenol group.
Recovery strategies should consider the timing of muscle function impairment post-exercise.
Supports 2021 - MolecularStrong
Protein-polyphenol drinks decreased muscle IL1R1 and IL1RL1 messenger RNA expression compared to the placebo.
Using protein-polyphenol drinks may help modulate inflammatory responses post-exercise.
Supports 2021 - Metabolic adaptationStrong
Menopause leads to significant metabolic alterations and central and visceral fat redistribution in women.
Practitioners should be aware of the metabolic changes that occur during menopause and consider them in treatment strategies.
Supports 2023 - Metabolic adaptationStrong
Changes in body composition at menopause influence risks of various health issues including cardiovascular disease and mental health disorders.
Health professionals should monitor and address the increased health risks associated with body composition changes during menopause.
Supports 2023 - HormonalStrong
Treatment of metabolic changes at menopause requires a flexible long-term strategy.
Practitioners should develop adaptable treatment plans for managing menopause-related metabolic changes.
Supports 2023 - MolecularStrong
The reductions in TG levels persisted at 26 weeks with a mean treatment difference of -12.7% compared to placebo.
ω-3-PL/FFA may provide long-term benefits in managing TG levels.
Supports 2022 - CellularStrong
Weight gain plays an important role in the pathogenesis of obstructive sleep apnea.
Weight management strategies should be emphasized in the treatment of obstructive sleep apnea.
Supports 2024 - Energy balanceStrong
Approximately 80% of adults in the United States do not meet the recommended guidelines for aerobic and muscle strengthening physical activity.
Public health initiatives should focus on increasing physical activity among adults.
Supports 2021 - CellularStrong
Both traditional and pyramid resistance training systems achieved upregulation of the antioxidant system in older women after 8 weeks.
Incorporating either traditional or pyramid resistance training can enhance antioxidant levels in older women.
Supports 2017 - CellularStrong
Both traditional and pyramid resistance training systems resulted in lower protein oxidation adducts compared to the control group.
Resistance training can help reduce protein oxidation in older women.
Supports 2017 - Metabolic adaptationStrong
Increased waist circumference (WC) during the first year of intensive lifestyle intervention (ILI) is associated with a higher risk for subsequent cardiovascular outcomes, independent of weight change.
Practitioners should monitor waist circumference in patients undergoing lifestyle interventions for diabetes management.
Supports 2020 - Metabolic adaptationStrong
ILI participants with increased waist circumference had an increased risk of primary cardiovascular outcomes, regardless of weight loss or weight gain.
Weight management strategies should also focus on waist circumference reduction to mitigate cardiovascular risks.
Supports 2020 - HormonalStrong
Preoperative fasting plasma C-peptide was predictive of increased chance of remission of type 2 diabetes after bariatric surgery (pooled difference in means = 0.93, 95% CI = 0.61 to 1.25, p < .001).
Practitioners may consider preoperative fasting C-peptide levels as a significant predictor for diabetes remission post-surgery.
Supports 2017 - Metabolic adaptationStrong
Tirzepatide induced a mean absolute HbA1c reduction across the three doses ranging from 2.3% to 3.0% in East Asian participants with type 2 diabetes.
Tirzepatide is effective in reducing HbA1c levels in East Asian individuals with type 2 diabetes.
Supports 2022 - HormonalStrong
SGLT-2 inhibitors and GLP-1 receptor agonists are effective in cardiovascular disease prevention among those with diabetes, heart failure, and chronic kidney disease.
Healthcare providers should consider these agents for patients with diabetes and related cardiovascular conditions.
Supports 2023 - Energy balanceStrong
Both guidelines provide guidance for recommended physical activity levels but acknowledge any physical activity, even less than recommended, is better than inactivity.
Encourage patients to engage in any level of physical activity to reduce cardiovascular risk.
Supports 2020 - CellularStrong
Aging and muscle disuse lead to the development of anabolic resistance and contribute to the loss of skeletal muscle mass.
Awareness of the effects of aging and disuse on muscle mass is crucial for intervention strategies.
Supports 2021 - MolecularStrong
Nitric oxide was significantly higher for high velocity resistance training (HVRT) compared to traditional resistance training (RT) after 30 minutes of exercise.
Practitioners may consider HVRT to enhance nitric oxide production in elderly hypertensive women.
Supports 2018 - HormonalStrong
GLP1-RA therapy appears safe and effective in patients with IBD.
GLP1-RA may be considered a treatment option for managing IBD.
Supports 2024